Eyepoint Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Based In Watertownmassachusettsthe Company Specializes In Innovative Ophthalmic Therapeuticsfocusing On Sustained Release Drug Delivery Systems For Serious Retinal Diseaseseyepoint Is Dedicated To Improving Patient Outcomes Through Advanced Drug Delivery Technologiesparticularly For Conditions Like Wet Age Related Macular Degenerationdiabetic Retinopathyand Post Surgical Inflammation The Companyae S Core Technology Includes Verisomeatechnologywhich Allows For Controlledlong Term Drug Releaseeyepoint S Approved Productdexycua Is An Fda Approved Single Dose Injection Designed To Treat Inflammation Following Cataract Surgerythe Company Is Also Developing Clinical Stage Candidates Such As Eyp 1901Aimed At Treating Various Retinal Conditionsand Vorolanibwhich Is Under Investigation For Its Novel Mechanism Of Action In Retinal Diseaseseyepoint Actively Collaborates With Partners To Expand Its Therapeutic Applications And Enhance Its Portfolio In Sustained Release Technologies
